OrganoClick has appointed Daniel Lund as new COO for the Group. He will head the Group operations with responsibility for purchasing, production and logistics. Daniel has more then 20 years of experience from production, quality assurance, and logistics from Astra Zeneca, Pfizer, Medivir and Bactiguard.
Daniel has a M. Sc. in Chemical Engineering from Luleå University of Technology. His most recent position has been the role as COO of Bactiguard, a medtech company which produces and supplies an antibacterial coating for various healthcare applications. Previous positions include Supply Chain Director for Pfizer Strängnäs, Supply Chain Director for Medivir and more then 14 years of leading positions within Astra Zeneca’s production in Södertälje within both production planning, logistics and quality assurance.
“We are very happy to welcome Daniel to OrganoClick. Daniel has a broad experience from chemical production within both big corporations and smaller entrepreneurial companies which makes him a very good fit as our new COO. His experience from production management, planning, quality assurance and logistics will be very valuable in our future global expansion”, says Mårten Hellberg, CEO of OrganoClick.
“I am very happy for the trust and the challenge. I have a strong engagement for sustainability and the environment and I am happy that I now can use my experiences within production and chemistry in a business where sustainability is an integral part of the business idea. I’m now looking forward in being part of OganoClick’s continuous journey in building a new Swedish industry based on green chemistry”, says Daniel Lund.
Daniel will start his position as COO and member of the management team 8 February 2020. At the same time, Mikael Wickström who currently holds the position as COO, will start his new position as Technical Director for OrganoClick.
RELATED NEWS
